Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.
复制标题
在癌症患者中使用草药的患病率：系统评价和荟萃分析。
DOI：
10.1155/2021/9963038
复制
发表时间：
2021
期刊：
影响因子：
--
通讯作者：
Sarki AM
中科院分区：
文献类型：
--
作者：
Asiimwe JB;Nagendrappa PB;Atukunda EC;Kamatenesi MM;Nambozi G;Tolo CU;Ogwang PE;Sarki AM
尽管癌症患者在多种肿瘤护理环境中使用草药，但在这种情况下草药使用的程度仍不清楚。本综述的目的是确定在不同地理环境和患者特征（年龄和性别类别）的癌症患者中草药使用的流行率。 检索了2000年1月至2020年1月期间发表数据的电子数据库，包括Medline（PubMed）、Google Scholar、Embase和African Index Medicus。采用随机效应荟萃分析，将报告癌症患者中草药使用流行率估计值的合格研究汇总。研究按世界银行区域和收入组别分组。进行亚组和荟萃回归分析，以探索异质性的来源。 总共有155项研究，809，065名受试者（53.95%女性）的数据符合入选标准。总体而言，癌症患者使用草药的汇总患病率为22%（95%置信区间（CI）：18%-25%），非洲（40%，95% CI：23%-58%）和亚洲（28%，95% CI：21%-35%）的患病率估计值最高。低收入和中等收入国家的合并患病率估计值较高（32%，95% CI：23%-42%），高收入国家较低（17%，95% CI：14%-21%）。成人癌症患者（22%，95% CI：19%-26%）的合并患病率估计值高于儿童癌症患者（18%，95% CI：11%-27%），女性患者（27%，95% CI：19%-35%）高于男性患者（17%，95% CI：1%-47%）。 草药被很大比例的癌症患者使用。这项审查的结果强调了需要草药整合在癌症护理。
Although herbal medicines are used by patients with cancer in multiple oncology care settings, the magnitude of herbal medicine use in this context remains unclear. The purpose of this review was to establish the prevalence of herbal medicine use among patients with cancer, across various geographical settings and patient characteristics (age and gender categories). Electronic databases that were searched for data published, from January 2000 to January 2020, were Medline (PubMed), Google Scholar, Embase, and African Index Medicus. Eligible studies reporting prevalence estimates of herbal medicine use amongst cancer patients were pooled using random-effects meta-analyses. Studies were grouped by World Bank region and income groups. Subgroup and meta-regression analyses were performed to explore source of heterogeneity. In total, 155 studies with data for 809,065 participants (53.95% female) met the inclusion criteria. Overall, the pooled prevalence of the use of herbal medicine among patients with cancer was 22% (95% confidence interval (CI): 18%–25%), with the highest prevalence estimates for Africa (40%, 95% CI: 23%–58%) and Asia (28%, 95% CI: 21%–35%). The pooled prevalence estimate was higher across low- and middle-income countries (32%, 95% CI: 23%–42%) and lower across high-income countries (17%, 95% CI: 14%–21%). Higher pooled prevalence estimates were found for adult patients with cancer (22%, 95% CI: 19%–26%) compared with children with cancer (18%, 95% CI: 11%–27%) and for female patients (27%, 95% CI: 19%–35%) compared with males (17%, 95% CI: 1%–47%). Herbal medicine is used by a large percentage of patients with cancer use. The findings of this review highlight the need for herbal medicine to be integrated in cancer care.
登录
查看更多内容
影响因子：
--
作者：
Abuelgasim KA;Alsharhan Y;Alenzi T;Alhazzani A;Ali YZ;Jazieh AR
通讯作者：
Jazieh AR
影响因子：
3
作者：
Afifi, Fatma U;Wazaify, Mayyada;Treish, Emad
通讯作者：
Treish, Emad
影响因子：
5.4
作者：
Chao, Te-Hsin;Fu, Pin-Kuei;Lin, Ching-Heng
通讯作者：
Lin, Ching-Heng
DOI：
10.1016/j.ejon.2005.03.010
发表时间：
2005-06-01
期刊：
European journal of oncology nursing : the official journal of European Oncology Nursing Society
影响因子：
--
作者：
Algier, Lale A;Hanoglu, Ziyafet;Kara, Figen
通讯作者：
Kara, Figen
影响因子：
4.2
作者：
Avci, Ilknur Aydin;Koc, Zeliha;Saglam, Zeynep
通讯作者：
Saglam, Zeynep